Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.
The endocannabinoid system and multiple sclerosis.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Episode 2 with Dr. Barbara Koppel on recommendations for cannabis in MS
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Biogen Idec receives notification of PDUFA date extension
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
Live Webcast: Assessing the Potential Impact of New and Emerging Disease-Modifying Therapies on the Initial Treatment and Comprehensive Management of Multiple Sclerosis
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
World Congress of Neurology (WCN) 2015
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
[Immunomodulation and neuroprotection in optic neuritis].
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.
Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.

Pages